Financials
- Market Capitalization 375.39 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2
Fiyat/satışlar oranı
11.96
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3122 | IPSC Century Therapeutics, Inc. - Common Stock | 2.13 USD | 0.00% | -7.79% | -7.79% | +267.24% | 384.16 M USD | ||
| 3133 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 12.91 USD | -1.53% | -10.41% | +12.85% | +95.90% | 375.40 M USD | ||
| 3142 | AVIR Atea Pharmaceuticals, Inc. - common stock | 4.70 USD | 0.00% | -4.08% | +6.82% | +46.42% | 376.13 M USD | ||
| 3174 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.62 USD | 0.00% | -6.67% | -2.12% | +11.06% | 362.77 M USD |